AviadoBio
ScaleupBiotech & Life SciencesBritish
Gene therapy company developing treatments for neurodegenerative diseases; lead programme AVB-101 targets frontotemporal dementia caused by GRN mutations (FTD-GRN), currently in Phase 1/2 clinical trials across the US, UK, Canada and Europe.
Locations
London, United Kingdom (Headquarters)
20 Water Street, London, Greater London, E14 5GX, United Kingdom
View on map